| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AVALANCHE BIOTECHNOLOGIES IN | 1,382,735 | 42,833,000 | 19.25% | ||
| 2 | Anacor Pharmaceuticals Inc | 1,178,474 | 28,837,000 | 12.96% | ||
| 3 | DBV Technologies | 565,000 | 26,334,000 | 11.83% | ||
| 4 | GW PHARMACEUTICALS PLC | 311,853 | 25,213,000 | 11.33% | ||
| 5 | DYAX CORP COM CVR | 2,000,859 | 20,249,000 | 9.10% | ||
| 6 | BIOCRYST PHARMACEUTICALS | 1,744,356 | 17,060,000 | 7.67% | ||
| 7 | RADIUS HEALTH INC | 525,000 | 11,025,000 | 4.95% | ||
| 8 | ZAFGEN INC COM | 541,480 | 10,024,000 | 4.50% | ||
| 9 | HERON THERAPEUTICS INC | 1,095,734 | 9,127,000 | 4.10% | ||
| 10 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 500,000 | 7,155,000 | 3.22% | ||
| 11 | NEUROCRINE BIOSCIE COM USD0.001 | 303,503 | 4,756,000 | 2.14% | ||
| 12 | LIPOCINE INC NEW | 669,921 | 4,093,000 | 1.84% | ||
| 13 | THERAPEUTICSMD INC | 846,500 | 3,928,000 | 1.77% | ||
| 14 | ZS PHARMA INC | 100,000 | 3,923,000 | 1.76% | ||
| 15 | OHR PHARMACEUTICAL INC | 477,000 | 3,458,000 | 1.55% | ||
| 16 | OCERA THERAPEUTICS INC | 703,730 | 3,448,000 | 1.55% | ||
| 17 | STEMLINE THERAPEUTICS INC | 71,000 | 884,000 | 0.40% | ||
| 18 | Alexza Pharmaceuticals Inc | 71,212 | 166,000 | 0.07% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-14-011751, filed 2014.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
